Back to search

Article

Phase 1b/2a study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) combined with low-dose nivolumab (LDN) in virally-suppressed patients with CHB on nucleos (t)ide analogues

2022-07-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6069fd80-b60e-5dda-a0d2-1ace716c2b83
DOI
10.1016/s0168-8278(22)02030-x
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Phase 1b/2a study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) combined with low-dose nivolumab (LDN) in virally-suppressed patients with CHB on nucleos (t)ide analoguesDOI 10.1016/s0168-8278(22)02030-x
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2Semantic proximity
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort studySemantic proximity
Safety and efficacy of immune checkpoint inhibitors in nasopharyngeal carcinoma patients with chronic hepatitis B virus infectionSemantic proximity
MVA-HBVac—A novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccinationSemantic proximity
Production, characterization and in vitro testing of HBcAg-specific VHH intrabodiesSemantic proximity
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programmingSemantic proximity
Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.Semantic proximity
Differential Reductions in Viral Antigens Expressed from CCCDNAVS Integrated DNA in Treatment Naïve HBEAG Positive and Negative Patients with Chronic HBV after RNA Interference Therapy with ARC-520Semantic proximity
Preclinical and clinical antiviral characterization of AB-836, a potent capsid assembly modulator against hepatitis B virus.Semantic proximity
A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.Semantic proximity
A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.Semantic proximity
Anti-HBsAg antibody mAb19-LS enhances antiviral immunity in humans with chronic hepatitis BSemantic proximity
Select a neighboring publication to make it the new centre.